The comparison between tirzepatide and semaglutide has become increasingly relevant for patients and doctors seeking the most effective weight loss treatment. The main difference is the mechanism of action: semaglutide acts only on the GLP-1 receptor, while tirzepatide acts on two receptors (GIP and GLP-1).
Comparative studies show tirzepatide (Mounjaro) can provide 20-25% body weight loss, while semaglutide (Ozempic/Wegovy) results in 15-20% loss.
This difference in efficacy can be explained by the dual action of tirzepatide on GIP and GLP-1 receptors.
Sigue tus análisis y ve cómo el protocolo afecta tus biomarcadores.
Registrar en la appSemaglutide is available in doses from 0.25mg to 2.4mg weekly. Tirzepatide ranges from 2.5mg to 15mg weekly. Both are administered by weekly subcutaneous injection.
Both medications start with low doses and increase gradually to minimize side effects. The escalation period varies from 4 to 16 weeks.
Sigue tus análisis y ve cómo el protocolo afecta tus biomarcadores.
Registrar en la appSide effects are similar: nausea, vomiting, diarrhea, and constipation. Cost varies significantly by region and availability.
Consult your doctor to determine which option is better for your specific weight loss case.
Rastreador de Análisis de Sangre
Registra y haz seguimiento de resultados de laboratorio a lo largo del tiempo. Observa cómo tu protocolo afecta tus biomarcadores — todo en una línea de tiempo.
Aviso: Este contenido es solo informativo y no sustituye la orientación médica profesional. Consulta siempre a tu médico antes de iniciar, cambiar o interrumpir cualquier tratamiento.